Douglas H. Campbell
75 Talavera Road
Macquarie Park, NSW 2113, Australia
Macquarie Park, NSW 2113, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.
Journal: Urologic oncology
Published: April 23, 2023
Novoglan device for treatment of adult phimosis: Novoglan-01 open-label clinical trial on safety, efficacy and tolerability.
Journal: Translational andrology and urology
Published: February 18, 2023
Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma.
Journal: Molecular pharmaceutics
Published: January 05, 2023
Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment.
Journal: Journal of nanobiotechnology
Published: July 18, 2022
Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study.
Journal: Analytical methods : advancing methods and applications
Published: May 25, 2022
Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery.
Journal: Molecular pharmaceutics
Published: April 19, 2022
Detection of rare prostate cancer cells in human urine offers prospect of non-invasive diagnosis.
Journal: Scientific reports
Published: March 04, 2022
Clinical development of an anti-GPC-1 antibody for the treatment of cancer.
Journal: Expert opinion on biological therapy
Published: January 24, 2022
Upconversion nanoparticle-assisted single-molecule assay for detecting circulating antigens of aggressive prostate cancer.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: July 14, 2021
Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: February 16, 2021
RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: January 04, 2021
Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target.
Journal: Therapeutic advances in medical oncology
Published: December 10, 2020
Last Updated: 09/26/2026